China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy, Safety, and Health Economics of Donanemab Treatment for Alzheimer's Disease in the Real World'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132189
Registration Time: 2026/09/10
Type: Observational study
Primary Sponsor: The Second Affiliated Hospital of Guangzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342784
Published by HT Digital Content Services with permission from Health Daily Digest....